Bishop N; Adami S; Ahmed SF; Anton J; Arundel P; Burren CP; Devogelaer JP; Hangartner T; Hosszú, Éva; Lane JM; Lorenc R; Makitie O; Munns CF; Paredes A; Pavlov H; Plotkin H; Raggio CL; Reyes ML; Schoenau E; Semler O; Sillence DO; Steiner RD
(2013)
BACKGROUND: Children with osteogenesis imperfecta are often treated with intravenous bisphosphonates. We aimed to assess the safety and efficacy of risedronate, an orally administered third-generation bisphosphonate, in ...